HCA Healthcare, Inc. Annual Report, Year Ended Dec 31, 2023

HCA Healthcare, Inc. (HCA) reported robust revenue growth in its 2023 annual report, with total revenues reaching $64.968 billion, a 7.9% increase over 2022. This growth was primarily driven by a 4.9% rise in equivalent admissions and a 2.8% increase in revenue per equivalent admission. Despite this top-line expansion, net income attributable to HCA Healthcare decreased to $5.242 billion from $5.643 billion in the prior year, impacted by the absence of significant facility sale gains recorded in 2022 and increased operating expenses, particularly in 'other operating expenses' which rose as a percentage of revenue. The company continues to invest heavily in its operations, with capital expenditures reaching $4.744 billion (excluding acquisitions) in 2023, indicating a commitment to enhancing facilities and services. HCA also returned significant capital to shareholders through share repurchases totaling $3.811 billion and dividends of $661 million in 2023. The company's strategic focus remains on expanding its presence in existing markets, achieving operational excellence, and recruiting top talent, positioning it for continued growth despite a competitive landscape and ongoing healthcare industry reforms.